Extensive assessment of fundamental factors in the development and validation of bioanalytical methods: Highlighting accuracy and reliability

Bioanalysis is a pivotal method employed in the pharmaceutical industry for the quantitative analysis of drugs and their metabolites within biological samples. It plays a crucial role in various aspects of pharmaceutical research, including bioequivalence, pharmacokinetic, and toxicokinetic studies. Method development, validation, and sample analysis are integral components of bioanalytical processes, ensuring the accuracy and reliability of results. Throughout each stage of analysis, careful evaluation is required to identify and mitigate any potential sources of interference, such as environmental factors, matrix effects, or procedural variations. Bioanalytical methods encompass a range of techniques utilized for the measurement of analytes within biological matrices, spanning from sample collection to data reporting. The establishment of robust bioanalytical methods is imperative throughout the drug discovery and development continuum, ultimately contributing to regulatory approval. Within this context, bioanalytical methods are extensively utilized to quantify pharmaceuticals and their metabolites within plasma matrices, facilitating both human clinical trials and non-human investigations.